These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6308148)
1. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity. Cools AR; Oosterloo SK J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148 [TBL] [Abstract][Full Text] [Related]
2. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour. Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067 [TBL] [Abstract][Full Text] [Related]
3. Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats. Megens AA; Cools AR Eur J Pharmacol; 1981 May; 71(2-3):247-58. PubMed ID: 6265235 [TBL] [Abstract][Full Text] [Related]
4. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism. van Oene JC; Houwing HA; Horn AS Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370 [TBL] [Abstract][Full Text] [Related]
5. Ergometrine and its biphasic action at dopaminergic receptors in the nucleus accumbens of rats. Cools AR Pharmacology; 1978; 16 Suppl 1():93-8. PubMed ID: 643907 [TBL] [Abstract][Full Text] [Related]
6. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors. Woodman OL; Medgett IC; Lang WJ; Rand MJ Eur J Pharmacol; 1981 Oct; 75(1):11-9. PubMed ID: 6119208 [TBL] [Abstract][Full Text] [Related]
7. Modulation of feeding and drinking behaviour by catecholamines injected into nucleus accumbens in rats. Pal P; Raj SS; Mohan M; Pal GK Indian J Physiol Pharmacol; 2000 Jan; 44(1):24-32. PubMed ID: 10919092 [TBL] [Abstract][Full Text] [Related]
8. Role of the nucleus accumbens in social memory in rats. Ploeger GE; Willemen AP; Cools AR Brain Res Bull; 1991 Jan; 26(1):23-7. PubMed ID: 1673081 [TBL] [Abstract][Full Text] [Related]
9. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings]. Costall B; Hui SC; Naylor RJ Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587 [No Abstract] [Full Text] [Related]
10. Effects of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on prejunctional alpha-adrenoceptors and prejunctional dopamine receptors in the rabbit ear artery. Medgett IC Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):141-4. PubMed ID: 6136918 [TBL] [Abstract][Full Text] [Related]
11. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives. Gundlach AL; Christie MJ; Beart PM Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029 [TBL] [Abstract][Full Text] [Related]
12. Mesolimbic noradrenaline: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of alpha-noradrenergic agonists. Cools AR; Ellenbroek B; van den Bos R; Gelissen M Behav Brain Res; 1987 Jul; 25(1):49-61. PubMed ID: 3620086 [TBL] [Abstract][Full Text] [Related]
13. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation. Baggio G; Ferrari F Life Sci; 1981 Mar; 28(13):1449-56. PubMed ID: 6113526 [No Abstract] [Full Text] [Related]
14. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens. Morgenstern R; Fink H Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255 [TBL] [Abstract][Full Text] [Related]
15. Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat. Pijnenburg AJ; Honig WM; Boudier HA; Cools AR; Van der Heyden JA; Van Rossum JM Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):103-15. PubMed ID: 984962 [TBL] [Abstract][Full Text] [Related]
16. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Cools AR Psychopharmacology (Berl); 1986; 88(4):451-9. PubMed ID: 3085132 [TBL] [Abstract][Full Text] [Related]
17. Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity. Schroeder JA; Hummel M; Unterwald EM Pharmacol Biochem Behav; 2004 Sep; 79(1):93-9. PubMed ID: 15388288 [TBL] [Abstract][Full Text] [Related]
18. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens. Vance MA; Blumberg JB Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats. Prinssen EP; Balestra W; Bemelmans FF; Cools AR J Neurosci; 1994 Mar; 14(3 Pt 2):1555-62. PubMed ID: 7907364 [TBL] [Abstract][Full Text] [Related]
20. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]